Apogee Therapeutics, Inc. (NASDAQ:APGE) Receives Consensus Recommendation of “Buy” from Analysts

Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) have been assigned a consensus rating of “Buy” from the eight analysts that are covering the firm, Marketbeat reports. Eight research analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have covered the stock in the last […]

Leave a Reply

Your email address will not be published.

Previous post Tuesday’s high school scores and highlights
Next post Sunoco LP (NYSE:SUN) Receives $62.71 Consensus Price Target from Analysts